Guidance on the use of glitazones for the treatment of type 2 diabetes /
National Institute for Clinical Excellence (Great Britain)
London : National Institute for Clinical Excellence,
2003.
"This guidance replaces Technology appraisal guidance no. 9 issued in August 2000 and Technology appraisal guidance no. 21 issued in March 2001."
Diabetes
Hypoglycemic agents